Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Guaifenesin is an expectorant commonly found in OTC products for the symptomatic relief from congested chests and coughs associated with cold, bronchitis, and/or other breathing illnesses. Guaifenesin possesses a storied history, having been originally formally approved by the US FDA in 1952 and continues to be one of very few - if not perhaps the only drug that is readily available...
- Mechanism
- Curator reviewed · 4 references
Although the exact mechanism of action of guaifenesin may not yet be formally or totally elucidated, it is believed that expectorants like guaifenesin function by increasing mucus secretion. Moreover, it is also further proposed that such expectorants may also act as an irritant to gastric vagal receptors, and recruit efferent parasympathetic reflexes that can elicit glandular exocytosis that is comprised of a less viscous mucus mixture. Subsequently, these actions may provoke coughing that can ultimately flush difficult to access, congealed mucopurulent material from obstructed small airways to facilitate a temporary improvement for the individual.
Consequently, while it is generally proposed that guaifenesin functions as an expectorant by helping to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive, there has also been research to suggest that guaifenesin possesses and is capable of demonstrating anticonvulsant and muscle relaxant effects to some degree possibly by acting as an NMDA receptor antagonist.
- Primary indication
- Guaifenesin is an expectorant that is indicated for providing temporary symptomatic relief from congested chests and coughs which may be due to a cold, bronchitis, and/or other breathing illnesses.Curator reviewed · 80 structured indications
- Formula / weight
- C10H14O4 · 198.2158 g/mol (avg)
- First approval
- Canada, 1996 · United States, 2003
- Also known as
- Glyceryl guaiacolate · guaiphenesin
- Brand names
- Broncotron
- Bronkaid
- Cheracol D
- Cheratussin
- Cheratussin Dac
- Codar Gf
- Coricidin Hbp Chest Congestion
- DM
- Deconex
- Delsym Cough Plus Chest Congestion DM
- Despec Reformulated Jun 2008
- Diabetic Tussin DM
- Diabetic Tussin EX
- Diphen
- Entex Lq
- Entex T
- G-zyncof
- Gilphex
- M-clear Wc
- Mar-cof Cg
- Mucinex
- Mucinex Children's Cough
- Mucinex Cough
- Mucinex D
- Mucinex DM
- Ninjacof Xg
- Obredon
- Pediacare Children's Cough and Congestion
- Refenesen
- Refenesen PE
- Rescon-GG
- Robafen
- Robafen DM
- Robitussin Chest Congestion
- Robitussin Cough & Congestion
- Robitussin Maximum Strength Cough Plus Chest Congestion DM
- Safetussin DM
- Scot-tussin
- Scot-tussin DM
- Siltussin
- Tusnel C
- Tusnel Diabetic
- +32 moreShow less
Resolves to
HSRJKNPTNIJEKV-UHFFFAOYSA-NSMILESCOC1=CC=CC=C1OCC(O)COWhat you can answer from here — as of September 23, 2026
Which other approved drugs treat the same conditions as Guaifenesin, and which companies have late-stage candidates in those indications?